Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023

February 22, 2024

https://www.globenewswire.com/news-release/2024/02/22/2833526/0/en/Morphic-Announces-Corporate-Highlights-and-Financial-Results-for-the-Full-Year-2023.html

-Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis (UC)-

-Enrollment on target in EMERALD-2 phase 2b global randomized trial of MORF-057 in UC-

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.